Latest News & Features
Americas
A US district court has dismissed Teva’s case against the FDA aimed at stopping the administration from approving generic versions of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate). 19 May 2014
Big Pharma
The English High Court has ruled that a patent covering vitamin dosage regimens for Eli Lilly’s lung cancer drug Alimta (pemetrexed disodium) would not be infringed by generic competitors. 16 May 2014
Americas
Novartis and Sun Pharma’s US subsidiary have settled litigation related to cancer drug Gleevec (imatinib mesylate) in the US, the companies announced today (May 15). 15 May 2014
Americas
Johnson & Johnson’s pharmaceuticals subsidiary Janssen has sued Mylan to stop it launching a generic version of Concerta (methylphenidate hydrochloride). 14 May 2014
Americas
Canadian pharmaceutical company Valeant announced yesterday (May 12) that it had settled all litigation related to its acne treatment Acanya (clindamycin phosphate and benzoyl peroxide) with Actavis. 13 May 2014
article
The pharmaceutical industry, as well as food and alcoholic drink manufacturers, could be under pressure from the spread of plain and standardised packaging, delegates at INTA's annual meeting in Hong Kong were told today, May 12. 12 May 2014
Americas
The US Court of Appeals for the Federal Circuit has ruled that mammals made using the cloning method that created Dolly the sheep are not patent eligible. 12 May 2014
Americas
UK-based medical technologies manufacturer Hill-Rom has sued General Electric (GE), claiming that the company infringes three patents covering hygiene monitoring systems. 9 May 2014
Americas
Acura Pharmaceuticals and Ranbaxy have agreed to settle their patent infringement litigation related to painkiller Aversion (oxycodone hydrochloride), once marketed by Pfizer under its registered trademark Oxecta. 8 May 2014
Americas
The US Federal Trade Commission (FTC) has filed an amicus brief in an antitrust case that concerns a “no-authorised-generic” settlement between Teva and GlaxoSmithKline (GSK). 7 May 2014